Charles C. Hsu, Ph.D.
Affiliations: | 2005 | Johns Hopkins University, Baltimore, MD |
Area:
Public Health, Genetics, Medicine and SurgeryGoogle:
"Charles Hsu"Cross-listing: PHTree
Parents
Sign in to add mentorJosef Coresh | grad student | 2005 | Johns Hopkins | |
(Genetic and traditional cardiovascular risk factors of kidney disease in the Atherosclerosis Risk in Communities (ARIC) study.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Ross HJ, Hu C, Higgins KA, et al. (2020) NRG Oncology/Alliance LU005: A phase II/III randomized clinical trial of chemoradiation versus chemoradiation plus atezolizumab in limited stage small cell lung cancer. Journal of Clinical Oncology. 38: TPS9082-TPS9082 |
Robbins C, Robbins J, Hsu C, et al. (2020) Practice Patterns of Head and Neck Radiation for Patients Presenting with De Novo Metastatic Disease: Implication of Radiation Regimen on Survival and Time Spent Receiving Radiation Therapy International Journal of Radiation Oncology Biology Physics. 108 |
Kim S, Bull DA, Hsu CH, et al. (2019) The Role of Adjuvant Therapy in Advanced Thymic Carcinoma: A National Cancer Database Analysis. The Annals of Thoracic Surgery |
Han JE, Yi SK, Wang S, et al. (2019) Neoadjuvant chemotherapy improves survival compared with concurrent chemoradiation alone in nasopharyngeal carcinoma patients with N3 disease. Head & Neck |
Kim S, Bull DA, Garland L, et al. (2018) Is There a Role for Cancer Directed Surgery in Early Stage Sarcomatoid or Biphasic Mesothelioma? The Annals of Thoracic Surgery |
Stea B, Skrepnik T, Hsu CC, et al. (2018) The role of radiation therapy in the treatment of metastatic cancer. Clinical & Experimental Metastasis |
Fang P, Jiang W, Davuluri R, et al. (2018) High lymphocyte count during neoadjuvant chemoradiotherapy is associated with improved pathologic complete response in esophageal cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology |
Herman JM, Jabbour SK, Lin SH, et al. (2018) Smad4 Loss Correlates With Higher Rates of Local and Distant Failure in Pancreatic Adenocarcinoma Patients Receiving Adjuvant Chemoradiation. Pancreas |
Han J, Yi S, Hsu C. (2018) Neoadjuvant Chemotherapy Associated With Improved Survival in High-Risk Nasopharyngeal Carcinoma Patients Treated With Definitive Concurrent Chemoradiation Therapy International Journal of Radiation Oncology*Biology*Physics. 100: 1324-1325 |
Shiraishi Y, Fang P, Xu C, et al. (2017) Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology |